Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last --
Change Today 0.00 / 0.00%
Volume 0.0
1099 On Other Exchanges
1099 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

sinopharm group co-h (1099) Snapshot

Previous Close
Day High
Day Low
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for SINOPHARM GROUP CO-H (1099)

Related News

No related news articles were found.

sinopharm group co-h (1099) Related Businessweek News

View More BusinessWeek News

sinopharm group co-h (1099) Details

Sinopharm Group Co. Ltd., together with its subsidiaries, operates as a wholesaler and retailer of pharmaceutical and healthcare products in the People’s Republic of China. The company operates in three segments: Pharmaceutical Distribution, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. This segment distributes medicines, medicine devices, and pharmaceutical products to hospitals, other distributors, retail drug stores, and clinics. The Retail Pharmacy segment operates or franchises a network of retail drug stores. As of December 31, 2014, this segment had 2,096 retail pharmacies, which included 1,747 retail pharmacies operated by company and 349 operated by franchisees. The Other Business segment produces and sells pharmaceutical products, chemical reagents, and laboratory supplies. The company also distributes building decoration, communication, and clothing products, as well as chemical reagents; imports and exports goods and technology; and provides business consulting, import agency services, other miscellaneous services, etc. In addition, it is involved in the real estate development, property rental, planting, and property management activities; provision of health consultation, medical consulting, market information consulting and investigation, and convention and exhibition services; and distribution of commodities and construction materials. Further, the company engages in enterprise management, consulting, technology services, and research and development in the field of biotechnology professional; cargo agency, warehousing, and shipping services; manufacture and trade of Chinese herbal medicines. The company is headquartered in Shanghai, the People’s Republic of China. Sinopharm Group Co. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd.

50,099 Employees
Last Reported Date: 04/9/15

sinopharm group co-h (1099) Top Compensated Officers

President, Executive Director and Member of S...
Total Annual Compensation: CNY2.8M
Head of Auditing Department and Supervisor
Total Annual Compensation: CNY895.0K
Compensation as of Fiscal Year 2014.

sinopharm group co-h (1099) Key Developments

Sinopharm Group Co. Ltd. Approves Amendments to the Articles of Association

Sinopharm Group Co. Ltd. announced that at the AGM held on June 18, 2015, the shareholders have approved the amendments to the articles of association of the company.

Sinopharm Group Co. Ltd. Declares Final Dividend for the Year Ended 31 December 2014, Payable on 31 July 2015

Sinopharm Group Co. Ltd. announced that the declaration and payment of a final dividend of RMB 0.31 per share (inclusive of tax) for the year ended 31 December 2014 was approved at the AGM. The final dividend will be paid on 31 July 2015 to the holders of H shares of the company whose names appear on the register of members of the company on 29 June 2015.

Qihoo 360 and Sinopharm Group Announce Framework Agreement for Strategic Cooperation

Qihoo 360 and Sinopharm Group declared to have inked framework agreement for strategic cooperation in forming an e-commerce JV building up medical e-commerce platform on the Internet, selling drugs online. Sinopharm Group will offer resources and drugs while Qihoo 360 build, operate and protect e-commerce platform for normal operation, offering technology support like search, cloud computing, big data and mobile applications.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
1099:HK $30.30 HKD -0.15

1099 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
China BCT Pharmacy Group Inc $0.01 USD 0.00
Chongqing Tong Jun Ge Co Ltd CNY17.15 CNY -1.00
View Industry Companies

Industry Analysis


Industry Average

Valuation 1099 Industry Range
Price/Earnings 20.8x
Price/Sales 0.3x
Price/Book 2.4x
Price/Cash Flow 21.9x
TEV/Sales 0.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SINOPHARM GROUP CO-H, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at